Strand Life Sciences has developed cancer diagnostic kit assess chronic disease at low cost

Strand Life Sciences develop cost effective cancer diagnostic kit

12:20 PM, 22nd April 2014
Strand Life Sciences research news
Dr Vijay Chandru, Chairman and CEO, Strand Life Sciences.

BANGALORE, INDIA: Strand Life Sciences, founded by Indian Institute of Science, in partnership with the Mazumdar-Shaw Medical Foundation, has developed a cancer diagnostic kit that can assess the likely occurrence of the chronic disease at one-fourth of the current diagnostic costs.

Bangalore-based Strand, a technology company in the field of genomics, has patented intellectual property to help early detection of breast and ovarian cancer among Indian patients by analyzing DNA sequences. Heredity is a major factor in the recurrence of cancer through generations. Brca I, Brca II, and TP53 are the three genes that can mutate and cause breast or ovarian cancer. Breast cancer is the most prevalent cancer among Indian women with approximately 1.5 lakh new patients being diagnosed every year. Nearly 7 lakh Indians die of some form of cancer every year, while over 10 lakh are newly diagnozed with the disease.

Strand’s cancer detection tests will be carried out at the Mazumdar-Shaw Centre for Translational Research located in Electronics City, at a cost of Rs 15,000 ($248.61) per screening. The results of the test would be delivered in two to three weeks. Dr Vijay Chandru, Chairman and CEO of Strand Life Sciences, said the company was able to re-engineer costs using its core strength of bioinformatics (applying computer science, statistics, mathematics and engineering to process biological data) and lowering the cost of chemical reagents used in the test by 30-40 per cent.

Cancer detection tests using traditional technology cost between Rs 50,000 ($828.71) and Rs 80,000 (1325.93) in India and about $2,000 to $3,000 abroad, said Dr Chandru. “This test would only be carried out on a doctor’s prescription, typically a family doctor who knows the history of the patient,” he added.

According to Chandru, the extreme form of prevention would be the removal of one’s breasts and ovaries. However, one could also change lifestyle patterns to reduce the risk of the genes mutating. “Regular check-ups like mammography would also have to be undertaken on a routine basis,” he added.

“We believe this collaboration will help us foster innovation and encourage in-depth research in the genomics space, thereby providing better care for patients with cancer and other genetic diseases,” said Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon and founder, Mazumdar Shaw Medical Foundation.

 

© TimesOfIndia News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Shin-Etsu to build rare earth magnet facility in Vietnam

TOKYO, JAPAN: Shin-Etsu Chemical Co Ltd has decided to establish a new rare earth magnet manufacturing plant in the Socialist Republic of Vietnam. The ...

Read more
Earth Day 2014, focus on green cities

NEW YORK, US: Every year on April 22, over a billion people in 190 countries take action for Earth Day. People are seen planting trees, clean up their ...

Read more
Using waste sulfur to make lens for infrared-light detection devices

ARIZONA, US: Research team led by University of Arizona has developed a new use for the sulfur left over from oil and natural gas refining: made into ...

Read more
254 Indian women die in US-funded clinical trial

NEW DELHI, INDIA: A 15-year US-funded clinical trial has led to death of 254 women in India. The trial was for a cervical cancer screening method and ...

Read more
Nufarm to close manufacturing facility in New Zealand

VICTORIA, AUSTRALIA: Nufarm Limited will close the facility at Otahuhu, near Auckland, New Zealand and further consolidate regional manufacturing acti ...

Read more
Newly developed technique improves detection of explosives

MANHATTAN, US: A Kansas State University engineer has developed a patented technique that improves military security and remotely detects improvised e ...

Read more
www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X